TR200909793A2 - Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative. - Google Patents

Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative.

Info

Publication number
TR200909793A2
TR200909793A2 TR2009/09793A TR200909793A TR200909793A2 TR 200909793 A2 TR200909793 A2 TR 200909793A2 TR 2009/09793 A TR2009/09793 A TR 2009/09793A TR 200909793 A TR200909793 A TR 200909793A TR 200909793 A2 TR200909793 A2 TR 200909793A2
Authority
TR
Turkey
Prior art keywords
combination
tiotropium
mometasone
dry powder
acid derivative
Prior art date
Application number
TR2009/09793A
Other languages
Turkish (tr)
Inventor
B�Lg�� Mahmut
Original Assignee
B�Lg�� Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B�Lg�� Mahmut filed Critical B�Lg�� Mahmut
Priority to TR2009/09793A priority Critical patent/TR200909793A2/en
Priority to PCT/TR2010/000188 priority patent/WO2011078817A1/en
Priority to EP10773177A priority patent/EP2515847A1/en
Publication of TR200909793A2 publication Critical patent/TR200909793A2/en
Priority to US13/531,972 priority patent/US8834931B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, solunum yolları rahatsızlıklarında kullanılmak üzere, tiotropium aktif maddesinin bir kortikosteroid ve etkili miktarlardaki kromoglisik asit ve/veya nedokromil türevi bir madde ile birlikte formüle edildiği inhalasyon yoluyla kullanılacak bir ilaç bileşimine dairdir.The present invention relates to a pharmaceutical composition for use by inhalation in which the active agent tiotropium is formulated with a corticosteroid and effective amounts of cromoglycic acid and / or a nedocromyl derivative for use in respiratory tract disorders.

TR2009/09793A 2009-12-25 2009-12-25 Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative. TR200909793A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2009/09793A TR200909793A2 (en) 2009-12-25 2009-12-25 Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative.
PCT/TR2010/000188 WO2011078817A1 (en) 2009-12-25 2010-09-22 Combination of tiotropium, mometasone and a cromoglicic acid derivative in dry powder form
EP10773177A EP2515847A1 (en) 2009-12-25 2010-09-22 Combination of tiotropium, mometasone and a cromoglicic acid derivative in dry powder form
US13/531,972 US8834931B2 (en) 2009-12-25 2012-06-25 Dry powder formulation containing tiotropium for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/09793A TR200909793A2 (en) 2009-12-25 2009-12-25 Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative.

Publications (1)

Publication Number Publication Date
TR200909793A2 true TR200909793A2 (en) 2011-07-21

Family

ID=43269323

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/09793A TR200909793A2 (en) 2009-12-25 2009-12-25 Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative.

Country Status (3)

Country Link
EP (1) EP2515847A1 (en)
TR (1) TR200909793A2 (en)
WO (1) WO2011078817A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011093810A2 (en) * 2010-01-28 2011-08-04 Bilgic Mahmut Dry powder pharmaceutical composition comprising tiotropium and mometasone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (en) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
CN1150890C (en) 1998-08-04 2004-05-26 杰格研究股份公司 Medicinal aerosol formulation
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
MXPA03003751A (en) * 2000-10-31 2004-10-15 Boehringer Ingelheim Pharma Novel medicament compositions based on anticholinergics and corticosteroids.
WO2009029028A1 (en) * 2007-08-24 2009-03-05 Astrazeneca Ab Breath- triggered inhaler with dose counter

Also Published As

Publication number Publication date
WO2011078817A1 (en) 2011-06-30
EP2515847A1 (en) 2012-10-31

Similar Documents

Publication Publication Date Title
UA112296C2 (en) DRY POWDER PREPARATION CONTAINING PHOSPHODIESTERASE INHIBITOR
EA201291306A1 (en) COMPOSITION OF DRY POWDER CONTAINING ANTIMUSCARINE MEANS
BR112013007304A2 (en) dry monovalent metal cation powders for inhalation
CL2016000735A1 (en) Dry powder inhaler comprising an inhalable pharmaceutical composition comprising fluticasone propionate, salmeterol xinafoate and a lactose carrier; Use to treat asthma or epoc.
TR201008226A2 (en) An inhalation device containing capsules.
TR201000681A2 (en) Dry powder formulations inhaled.
BR112015027017A2 (en) inhalable pharmaceutical compositions and inhaler devices containing the same
UA100777C2 (en) Inhalable particles comprising tiotropium
EA201201397A1 (en) INHALER CONTAINING DISTRIBUTED GLISTER PACKING
TR201000733A2 (en) Pharmaceutical compositions comprising fluticasone, tiotropium and sodium chromoglycate.
TR200907917A2 (en) Dry powder inhaler.
EA201201390A1 (en) PUSH-BUTTON DEVICE
EA201201389A1 (en) INHALER, CREATING TURBULENCE
CO6270213A2 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING MONTELUKAST ACID AND A DEPDE-4 UNHIBITOR OR AN INHALED CORTICOESTEROID FOR INHALATION ADMINISTRATION
TR200909792A2 (en) Dry powder combination containing tiotropium, corticosteroid and a combination of chromoglycic acid derivative
TR200909793A2 (en) Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative.
TR201007250A2 (en) Formulation containing cellobiose.
TR200909790A2 (en) Combination of dry powder containing a combination of tiotropium, formoterol and a chromoglycic acid derivative.
TR200907914A2 (en) Pharmaceutical composition in the form of a dry powder containing corticosteroid.
TR200909789A2 (en) Dry powder combination containing tiotropium, budesonide and a chromoglycic acid derivative combination
TR200909788A2 (en) Dry powder formulation suitable for inhalation with tiotropium
TR200803525A2 (en) Powder inhaler.
TR200907913A2 (en) Pharmaceutical composition in dry powder form for inhalation
TR200907237A2 (en) Tiotropium dry powder combination
WO2011093812A3 (en) Pharmaceutical formulation comprising tiotropium and budesonide in dry powder form